NCI-60 Whole Exome Sequencing and Pharmacological CellMiner Analyses-Reference-Cited by-同舟云学术

NCI-60 Whole Exome Sequencing and Pharmacological CellMiner Analyses

Published:2014-07-17 Issue:7 Volume:9 Page:e101670
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Reinhold William C.,Varma Sudhir,Sousa Fabricio,Sunshine Margot,Abaan Ogan D.,Davis Sean R.,Reinhold Spencer W.,Kohn Kurt W.,Morris Joel,Meltzer Paul S.,Doroshow James H.,Pommier Yves

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference71 articles.

1. Dyment DA, Cader MZ, Chao MJ, Lincoln MR, Morrison KM, et al.. (2012) Exome sequencing identifies a novel, multiple sclerosis susceptibility variant in the TYK2 gene. Neurology.

2. Doherty D, Bamshad MJ (2012) Exome sequencing to find rare variants causing neurologic diseases. Neurology.

3. Exome sequencing identifies novel candidate mutations in idiopathic;F Moldovan;Stud Health Technol Inform,2012

4. Choi BO, Koo SK, Park MH, Rhee H, Yang SJ, et al.. (2012) Exome sequencing is an efficient tool for genetic screening of Charcot-Marie-Tooth Disease. Hum Mutat.

5. Johnston JJ, Rubinstein WS, Facio FM, Ng D, Singh LN, et al.. (2012) Secondary Variants in Individuals Undergoing Exome Sequencing: Screening of 572 Individuals Identifies High-Penetrance Mutations in Cancer-Susceptibility Genes. Am J Hum Genet.

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sarcoma_CellminerCDB: A tool to interrogate the genomic and functional characteristics of a comprehensive collection of sarcoma cell lines;iScience;2024-06

2. Safety and efficacy of canakinumab treatment for undifferentiated autoinflammatory diseases: the data of a retrospective cohort two-centered study;Frontiers in Medicine;2023-11-15

3. YAP at the Crossroads of Biomechanics and Drug Resistance in Human Cancer;International Journal of Molecular Sciences;2023-08-06

4. CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations;Cancer Research;2023-05-04

5. National Cancer Institute (NCI) Program for Natural Product Discovery: Exploring NCI-60 Screening Data of Natural Product Samples with Artificial Neural Networks;ACS Omega;2023-03-01